Cyclerion Therapeutics Inc. (CYCN) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Cyclerion Therapeutics In...

    NASDAQ: CYCN · Real-Time Price · USD
    2.55
    0.19 (7.93%)
    At close: Sep 11, 2025, 3:59 PM
    2.58
    1.26%
    After-hours: Sep 11, 2025, 06:41 PM EDT

    Cyclerion Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 3.23M 7.57M 13.38M 53.96M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 5.35M 5.35M n/a n/a
    Other Long-Term Assets
    		 n/a n/a 2.04M 2.41M
    Receivables
    		 556K n/a 96K 100K
    Inventory
    		 n/a n/a 805K 928K
    Other Current Assets
    		 16K 11K 537K 468K
    Total Current Assets
    		 4.22M 8.02M 14.82M 55.46M
    Property-Plant & Equipment
    		 n/a n/a 1.22M 1.47M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 5.35M 5.35M 3.26M 3.87M
    Total Assets
    		 9.57M 13.37M 18.08M 59.33M
    Account Payables
    		 390K 1.2M 2.97M 1.83M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a n/a n/a
    Other Current Liabilities
    		 63K 102K 3.99M 7.28M
    Total Current Liabilities
    		 725K 2.09M 7.63M 11.09M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 n/a n/a 2.97M n/a
    Total Liabilities
    		 725K 2.09M 7.63M 11.09M
    Total Debt
    		 n/a n/a n/a n/a
    Common Stock
    		 n/a n/a n/a n/a
    Retained Earnings
    		 -267.49M -264.42M -259.15M -215.08M
    Comprehensive Income
    		 n/a -12K -20K -23K
    Shareholders Equity
    		 8.85M 11.29M 10.45M 48.25M
    Total Investments
    		 5.35M 5.35M n/a n/a

    Add to Watchlist